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Abstract
Recent advances in de novo protein evolution have made it possible to create synthetic proteins from unbiased libraries that
fold into stable tertiary structures with predefined functions. However, it is not known whether such proteins will be
functional when expressed inside living cells or how a host organism would respond to an encounter with a non-biological
protein. Here, we examine the physiology and morphology of Escherichia coli cells engineered to express a synthetic ATP-
binding protein evolved entirely from non-biological origins. We show that this man-made protein disrupts the normal
energetic balance of the cell by altering the levels of intracellular ATP. This disruption cascades into a series of events that
ultimately limit reproductive competency by inhibiting cell division. We now describe a detailed investigation into the
synthetic biology of this man-made protein in a living bacterial organism, and the effect that this protein has on normal cell
physiology.
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Introduction
The emerging field of synthetic biology is divided into two
broad classes, both of which attempt to understand and harness
basic underlying principles of living systems[1]. One uses
engineering concepts to design and build artificial gene networks
from component parts that exist in nature, but once assembled
function in unnatural ways[2,3,4,5]. Early efforts in this area have
resulted in examples of engineered microorganisms, mainly
Escherichia coli and Saccharomyces cerevisiae, with synthetic biology
frameworks that function as toggle switches[6], self-assemble into
oscillating networks[7], and establish predator-prey ecosystems[8].
A different area of synthetic biology relies on chemistry and
chemical biology to develop unnatural chemical systems that
emulate the emergent properties of life or function inside living
cells[9,10]. This area of synthetic biology is credited with
establishing fundamental insights into the origins and biology of
the cell[11,12,13,14,15,16], as well as creating an alternative
genetic system that is now used as a diagnostic tool to detect HIV
and hepatitis in infected patients[17,18].
One unexplored avenue within the chemical side of synthetic
biology involves examining the physiology of man-made proteins
inside living cells. While recombinant DNA technology has
produced many examples where natural proteins have been
engineered with properties that are desirable for biotechnology,
such as improved stability or expanded substrate specificity, these
structures all derive from sequences whose ancestors can be traced
back to nature[19,20,21]. Recent progress in de novo protein design
and de novo protein evolution has shown that it is now possible to
create novel synthetic proteins using methods that no longer rely
on natural protein scaffolds as starting points[22]. Examples of
man-made proteins include a 4-helix bundle created by binary
patterning[23], computational design of an a/b protein called
Top7[24], and an in vitro evolved ATP-binding protein known as
Family B[25]. While all three proteins adopt discrete structures,
with Top7 and Family B collapsing into novel folds, only the de
novo evolved ATP-binding protein exhibits a predefined func-
tion[25]. Our previous experience in the directed evolution and
structure determination of the Family B protein led us to wonder
how living cells might respond to an encounter with a man-made
protein whose creation never involved heterologous expression in
a host organism[26,27,28]. Would such an encounter reveal
something new about biological pathways or help explain why
certain protein folds are not observed in nature? One possibility is
that natural selection may have biased the set of proteins found in
nature to favor only those structures that are well suited to the
cellular environment. This would suggest that proteins with non-
cellular origins might have structures or functions that are
incompatible with normal cellular biology, which of course would
significantly limit their use in synthetic biology.
We therefore designed a set of experiments that enabled us to
monitor the physiology and morphology of Escherichia coli cells
transformed with a plasmid containing the synthetic gene to a well
characterized and highly evolved variant of the Family B protein
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synthetic progenitor to bind ATP with high affinity and specificity,
and solved the x-ray crystal structure of this protein to a resolution
limit of 1.65 A ˚[28]. This man-made ATP-binding protein
(Figure 1) adopts a novel zinc-nucleated a/b-fold with a unique
topology. The ATP-binding motif differs considerably from
traditional ATP-binding motifs found in nature[29], suggesting
that there are many solutions to the problem of a how a protein
can fold to bind ATP. While biochemical and structural
characterization of protein DX required expression and purifica-
tion from E. coli lysate, no systematic attempt has yet been made to
characterize the interactions between this protein and any host
organism. Given the importance of ATP as the main energy
source of the cell and central metabolite and substrate in many
enzymatic pathways, we reasoned that expression of protein DX in
E. coli would elicit one or more biochemical responses due to the
function of DX as a high affinity ATP-binding protein. The
following study describes the first investigation into the synthetic
biology of a non-biological protein in a living bacterium, and its
consequences on cell physiology.
Results
Expression of a Man-Made Protein in Bacteria
To evaluate the effect of expressing a completely synthetic
protein inside a living host organism, a pBAD18 vector containing
the DX gene under the control of an arabinose-inducible
promoter (pBAD18-DX) was transformed into the commercial
E. coli strain Top10[30]. Control strains were constructed with an
empty vector (pBAD18-E) and pBAD18 vector expressing human
ubiquitin (pBAD18-UBQ). Ubiquitin was chosen based on its
similar size to protein DX, well-folded nature, and absence of a
native homologue in E. coli. We cultured all three strains in Luria-
Bertani broth (LB) media containing arabinose inducer and
monitored cell density and growth over the course of a 10-hour
period. Cells were plated onto LB-agar plates in 10-fold serial
dilutions, beginning with a 1000-fold dilution and colonies were
inspected after overnight incubation at 37uC. We observed that
the number of colony forming units (CFUs) present in the DX-
producing strain increased during the first four hours of induction.
However, after four hours of induced growth, the number of CFUs
present in the DX-producing strain remained constant, while the
number of CFUs observed in the control strains continued to
increase with time (Figure 2). Close inspection of the CFUs formed
by the pBAD18-DX strain indicated that at longer induction times
the DX-producing colonies appeared smaller, darker, and more
flat than colonies observed in either control strain (Figure S1). This
effect manifests after only one hour when protein expression is
maintained by plating the DX-producing strain onto solid media
containing inducer. When the DX-producing strain is both
cultured and plated in the absence of inducer the resulting CFUs
appear indistinguishable from CFUs produced in the control
stains, and only minor differences are observed when the DX-
producing strain is cultured in liquid media without inducer but
plated onto solid media containing the arabinose inducer.
Metabolic Effect of DX Expression
Limited propagation of the DX-producing strain under post-
induction conditions indicates that expression of the DX gene in E.
coli leads to interference with the normal mechanism of cell growth
and division. This type of response can occur when cells deplete
their available nutrients by translating proteins at abnormally high
levels [31]. To test this possibility, we monitored protein formation
by western blot analysis using an anti-Flag antibody to detect a Flag
epitope that was engineered intothe amino-terminus of the DX and
ubiquitin protein constructs. Strains expressing DX and ubiquitin
were analyzed on an hourly basis following arabinose induction in
liquid cultures. Inspection of the resulting gels (Figure 3a) revealed
that protein DX is translated at lower levels and at later times than
ubiquitin (4 versus 2 hours, respectively). Comparison of both time-
course experiments to the DX standard in the control lane
demonstrated that ubiquitin, which is present after two hours of
induced growth, is produced at levels that are 3-4-fold higher than
DX. This result indicates that the limited growth of the DX-
producing strain is not due to broad nutrient depletion caused by
protein over-expression, but rather a systemic effect in which
protein DX interferes with one or more normal cellular processes.
We performed a standard immunoprecipitation assay to
evaluate the possibility that protein DX was interfering with cell
division by binding to one or more endogenous E. coli proteins.
The DX, ubiquitin, and empty-vector strains were cultured for
four hours with induction, lysed, and the cell contents were
immobilized onto anti-Flag sepharose beads. The beads were
thoroughly washed in buffer containing 0.1% nonidet-P40 and
1 mM DTT and the protein that remained bound to the resin was
eluted with SDS and analyzed by denaturing gel electrophoresis.
Silver-stained images (Figure 3b) of the resulting gels revealed the
presence of two faint bands at 30 and 70 kDa, one intermediate
band at 75 kDa, and one dark band at 25 kDa in the DX lane that
were not present in the elution fractions taken from either control
strain or the bead-only lane. Whether these proteins bind directly
to DX or bind other E. coli proteins that bind to DX is not clear. It
Figure 1. X-ray crystal structure of protein DX with translucent
surface rendering. Protein DX adopts a novel zinc-nucleated a/b-fold
with a topology not yet been observed in nature. The zinc and ATP
ligands are colored according to atom type (PDB: 2P09).
doi:10.1371/journal.pone.0007385.g001
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growth phenotype given that all but one are present at much lower
concentrations than protein DX. The observation that protein DX
does not bind to many proteins inside the cell is interesting, and
suggests that protein DX is not any stickier than a typical protein
found in nature. This result is surprising, given that protein DX
was created by a purely cell-free method with no direct selective
pressure to function inside a cell.
Figure 2. Expression characteristics of E. coli cells expressing protein DX. E. coli cells containing the DX, ubiquitin, or empty vector were
induced in liquid media with arabinose and spotted in 10-fold dilutions onto solid agar plates that either contained (column 2) or were devoid
(column 1) of the arabinose inducer. A series of control experiments were performed in parallel in which uninduced cells were plated onto solid
media that contained (column 4) or were devoid (column 3) of arabinose.
doi:10.1371/journal.pone.0007385.g002
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important substrate in many biological pathways, we reasoned that
the function of protein DX as an ATP-binding protein might
interfere with cell division by altering the level of free ATP inside
the cell. To examine this possibility, we monitored the intracellular
levels of ATP over the course of a 10-hour period. We cultured all
three strains in LB media containing inducer, and measured the
amount of intracellular ATP on an hourly basis using a highly
sensitive bioluminescent assay. Cell samples were normalized to
total cell protein and a standard linear calibration was used to
determine the absolute quantity of ATP in each sample. In this
assay, the ATP levels in the DX strain remained within one
standard deviation of the control strains during the first three
hours of induced growth (Figure 3c). After three hours, ATP levels
in the DX-producing strain begin to rise, while ATP levels in the
control strains fall. This trend continues until a point at which a
,10-fold difference is evident between the DX and control strains.
The fact that intracellular levels of ATP begin to change at the
same time that protein DX is first detected inside the cell, and that
both occur contemporaneously with the transition of the DX-
producing strain from normal to reduced cell growth, is consistent
with the hypothesis that the function of DX as an ATP-binding
protein is responsible for the reduced growth phenotype.
Reversibility of the DX Phenotype
The observation that our synthetic protein was having a
dramatic effect on cell proliferation led us to wonder whether DX
functioned as a bactericidal or bacteriostatic agent. To examine
this question in greater detail, we cultured the DX-producing
strain for 10 hours under induction, removed the inducer and
allowed the cells to continue growing for an additional eight hours.
Cells taken during the recovery period were plated onto LB-agar
plates in 10-fold serial dilutions. The resulting plates (Figure 4a)
were compared to control cells in which the empty vector was
separately cultured in the presence of the bacteriostatic agent
Figure 3. Biochemical properties of E. coli cells that express DX.
(a) Western blot showing expression of DX and ubiquitin. The blots are
normalized to a DX standard of 120 mg. Lanes 1–10 corresponds to 1–
10 hours of induced growth. (b) Immunoprecipitation of protein DX.
Lane 1, protein standards; lanes 2–4, crude lysate; lanes 5–7, wash
fractions; lanes 8–10, immuno-precipitate. In each case, samples are
given in order of DX, ubiquitin, and empty vector, respectively. Lane 11
is a bead only control. (c) Quantitative chemiluminescence analysis of
ATP levels in cells expressing DX (N), ubiquitin (m), and empty vector
(&).
doi:10.1371/journal.pone.0007385.g003
Figure 4. Reversibility of DX growth suppression. (a) E. coli cells
cultured in the presence of inducer for 10 hours were allowed to
recover in the absence of inducer for a variable amount of time (0–
8 hours). Cells expressing protein DX were compared to control cells
containing the empty vector exposed to a bacteriostat (tetracycline),
bactericide (kanamycin), or no additional antibiotic. (b) E. coli cells were
cultured in the presence of inducer for varying amounts of time (4–
14 hours) and allowed to recover for 4 hours in LB media free of
inducer.
doi:10.1371/journal.pone.0007385.g004
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absence of either antibiotic. We observed that under our
expression regime, protein DX appears to function as a
bacteriostatic agent since the DX strain displayed a phenotype
that is similar to the tetracycline control. To confirm this
observation, we used a time course experiment to monitor CFU
formation during eight hours of expression and eight hours of
recovery. We then performed a two-way ANOVA analysis with
respect to time and cell culture type to determine whether the
differences observed were statistically significant (Figure S2, Table
S1). We found that there were significantly fewer cells in the DX-
expressing culture than either the empty or ubiquitin control
cultures (p-value,0.001) after three hours of recovery in the
absence of arabinose. During the expression period, the number of
cells observed in the DX culture did not differ significantly from
the tetracycline control even though the tetracycline culture had a
lower number of CFUs at each time point. We noticed that cells
containing the empty vector appear to exert a slight increase in
abundance after removal of the arabinose inducer. This effect is
presumably due to a small inhibitory effect of arabinose on the
growth rate of E. coli. The observation that the DX-expressing
culture behaves similar to the tetracycline treated culture supports
our hypothesis that the DX protein functions as a bacteriostatic
agent.
However, unlike cells grown in the presence of tetracycline,
which propagate normally when re-suspended in antibiotic-free
media, the DX-producing strain exhibits a delay in its recovery
response when re-suspended in LB media devoid of inducer.
Despite the fact that colony maturity was quickly restored, the
number of CFUs observed in the DX-producing strain did not
increase in abundance during the recovery period. To determine if
this lag in cell division is related to abnormalities observed in
colony appearance, we repeated this experiment by varying the
induction time while maintaining a constant recovery period of
four hours in LB free of inducer. Cells induced for 4 and 10 hours
resulted in colonies that are indistinguishable from the tetracycline
control. Cells induced for 14 hours produced colonies (Figure 4b)
that are similar in appearance to colonies observed when protein
expression is maintained by plating cells onto solid media
containing inducer (Figure S2). This result is consistent with our
earlier observation that colony abnormality is more severe when
protein expression is maintained for extended periods of time, and
suggests that longer expression times leads to the accumulation of
large numbers of unhealthy cells.
Light Microscopy Studies
We used phase contrast microscopy to examine the morphology
of E. coli cells that were actively expressing the synthetic DX gene.
We were particularly interested in determining whether DX had
an effect on cell growth, as some bacteriostatic agents will inhibit
growth and division of a cell, while others will inhibit only division
but allow cell growth to continue[31]. Bacteriostatic agents that
only inhibit cell division result in a filamentous phenotype that is
easily observed by light microscopy. In a nine-hour time course
experiment (Figure 5), cells taken within the first three hours of
induction appeared indistinguishable from the control cells. After
three hours, cells taken from the DX strain began to filament,
while the control strains remain normal. Close inspection of
individual micrographs indicated that the length of filamentation
increases with induction time. To quantify this progression, we
compiled a statistical sampling of cells and measured the length of
these cells after each hour of induction. The median length of cells
expressing DX increased from 3.2 to 6.1 mm when cells were
induced for two and six hours, respectively. After six hours, the
rate of cell elongation stabilizes to a point at which the population
of cells have a median length of ,6.5 mm. No difference was
observed between un-induced cells that contain the pBAD18-DX
plasmid and the control cells, and both of these cells remained
within one standard deviation of their initial value. This result
demonstrates that the DX-strain has two cellular phenotypes—one
that leads to cell filamentation and one that causes the cessation of
further cell elongation.
Encouraged by the observation that protein DX functions as a
bacteriostatic agent, we transformed the pBAD18-DX and
pBAD18-E plasmids into the MG1655 strain of E. coli K-12 and
S. typhimurium strain LT-2 to determine if the filamentous
phenotype could be elicited in other types of bacteria. MG1655
represents a less engineered form of E. coli relative to the Top10
strain, which is heavily modified for laboratory use. Phase contrast
microscopy (Figure 6) reveals that expression of DX in these two
strains results in the same filamentous phenotype observed in the
TOP10 strain. This demonstrates that DX expression disrupts
bacterial growth in multiple bacterial strains, which suggests that
DX is targeting a conserved bacterial pathway.
Transmission Electron Microscopy Studies
We used transmission electron microscopy (TEM) to examine
the filamentous phenotype at higher resolution. We analyzed the
DX-producing strain in E. coli Top 10 cells after three, four, and
five hours of induced growth. We focused our analysis on data
obtained after three hours as these micrographs produced the
highest quality images. Micrographs taken of uninduced cells show
E. coli cells at various stages of cell division. All of the uninduced
cells appear healthy and range in length from 1–2 mm with the
longest actively dividing cell having a length of 2.2 mm. Illustrated
in figure 7a is a typical example of a healthy bacteria cell
undergoing division. The micrograph shows the separation of
chromosomes into dividing cells and the initial formation of a
division septum at the cell center. The cell wall and cytoplasmic
membrane are clearly visible, as are ribosomes, which stain as dark
spots scattered throughout the cytoplasm. In contrast, micrographs
taken after induction (Figure 7b) show cells that have grown into
long filaments, some of which exceed 12 mm in length.
Filamentous cells sectioned along their longitudinal axis contain
multiple well-defined nucleoids that segregate evenly along the
length of the cell with ribosomes scattered throughout the
cytoplasm. None of the induced cells have a septum, indicating
that these cells are not actively dividing. However, these cells do
contain large numbers of vesicles (Figure 7c–d) in their outer
membrane, which could suggest that the host organism is trying to
remove protein DX from the cell. In one case we observed 21
vesicles along a short 1.7 mm section of membrane. Only three
such structures were observed in a typical control cell of similar
length. These images demonstrate that the filamentous phenotype
is not caused by failure of chromosomes to divide or segregate
[31], but rather some other mechanism that interferes with cell
division.
Differential Gene Expression by Microarray Analysis
We examined the effects of DX expression on the global
regulatory pathways of E. coli using a time-dependent microarray
analysis assay[32]. We isolated cellular RNA at half-hour intervals
over a 4-hour period starting with induction. Cellular RNA was
reverse transcribed into cDNA with Alexa-647 and Alexa-555
fluorescent dyes used to label the cDNA from induced and
uninduced cells, respectively. Pairs of differentially labeled cDNA
samples from each time point were hybridized to a custom Agilent
E. coli expression array on which eight sets of the 4,169 E. coli K-12
Biology of a Synthetic Protein
PLoS ONE | www.plosone.org 5 October 2009 | Volume 4 | Issue 10 | e7385Figure 5. Analyzing the effect of DX expression on cell morphology. Phase-contrast micrograph images taken between 2 and 9 hours post-
induction show the filamentous phenotype in cells expressing protein DX. The unbiquitin and empty control strains appear normal at all times of
induced growth. Images were acquired at 406magnification.
doi:10.1371/journal.pone.0007385.g005
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was extracted using Genepix, loaded into GeneSpring 7.2 and
filtered according to flags and reproducibility. We first selected
genes that change under a steady-state model of increasing or
decreasing expression over time. We then used regression analysis
to match a theoretical pattern of expression, which increases or
decreases smoothly over the 4-hour period. From this analysis, we
were able to identify 195 genes whose expression matched the
rising pattern (Table S2) and 184 genes whose expression matched
the declining pattern (Table S3). Of the 195 genes that rose over
time, 44 represent ORFs of unknown function. The remaining
genes, when analyzed using the Database for Annotation,
Visualization, and Integrated Discovery (DAVID)[33], fell into
four clusters of categories: oxidoreductases, taurine and sulfur
metabolism associated genes, membrane proteins, and flagellar
and chemotactic genes. Each of these clusters contained multiple
gene ontology classifications that were over represented when
compared with a random list of E. coli genes of similar size. We
considered Gene categories to be significantly over-represented if
DAVID returned a P-value of 0.1 or less.
Based on these initial findings, we decided to perform a more
extensive analysis of genes related to the over-represented
ontological categories. A genome-wide analysis of all genes
annotated with the ontology term ‘‘taxis’’ reveals that many of
these genes show mild time-dependent up-regulation in cells that
express the DX gene (Table S4). This includes significant up-
regulation of flhC/D, which acts as a sigma factor for class II
flagellar genes[34]. Genome-wide analysis of all genes annotated
with the gene ontology term ‘‘sulfur metabolism’’ reveals that
while many show a mild time-dependent up-regulation, several,
especially the sufABCDES genes, show a strong time dependent
down-regulation (Table S5). Oxidoreductases and membrane
proteins were not analyzed at a genome wide level due to the
number and variety of genes involved in these pathways, which
will require an independent analysis.
Of the 184 genes that decline in expression over time, 38 were
ORFs of unknown function. When analyzed with DAVID, the
remaining genes segregate into six broadly defined categories:
signal proteins, phosphoric ester hydrolyses, amino acid and
nitrogen compound biosynthetic proteins, disaccharide metabo-
lism proteins and glycosidases, lipoprotein and lipid binding
proteins, and pyrimidine nucleotide biosynthetic proteins. Since
rpoS is known to be an important transcriptional regulator[35], and
linear regression analysis indicated that it matched a trend of
gradual reduction in expression over time, we examined the
expression of genes that this protein regulates. We found that the
majority of genes identified as being induced by rpoS were
repressed in cells expressing the DX gene (Table S6). This is
interesting because rpoS is involved in regulating the transition
from exponential to stationary growth, which is delayed or
inhibited in cultures that express the DX gene. Of course, rpoS is
also involved in the stress response caused by many other stimuli,
so it is unclear if the drop in rpoS expression is related to expression
of the DX gene.
Based on the DX-induced filamentous phenotype, we examined
constituents of the SOS pathway and purine biosynthesis pathway,
as well as a selection of genes involved in cell division and ATP
synthesis. Genes in the SOS pathway, which is the primary means
by which E. coli enters into filamentous growth[31], show no
consistent up-regulation over time (Table S7). In fact, sulA, the
central cell division suppression protein of the SOS pathway, is
reduced in expression by more than two-fold over the course of
4 hours, while lon, which deactivates sulA, increases in expression
during that same period of time. This is the opposite expression
pattern that one would expect for an SOS response[31].
Examination of other genes involved in cell division shows no
suppression of the fts cell division proteins or the minCDE proteins
involved in proper placement of the ftsZ ring complex (Table
S8)[31], however, zapA, which promotes polymerization of the
FtsZ ring, is down-regulated nearly four-fold. To determine if the
Figure 6. Species and strain specificity of DX filamentous phenotype. Phase-contrast micrograph images of E. coli TOP10, E. coli K12
MG1655, and S. typhimurium LT-2 taken at 9 hours post-induction of the DX protein. Control cells of each strain containing the empty vector are
included to provide a basis of comparison. Images were acquired at 406magnification.
doi:10.1371/journal.pone.0007385.g006
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assay (Figure 3c) could result from greater activity in ATP
biosynthesis, we examined the expression levels of purine
biosynthesis and ATP synthase genes (Table S9). The majority
of genes involved in purine biosynthesis were either down
regulated or unaffected following expression of DX; and purR,
the repressor of purine biosynthesis, was up-regulated. In contrast,
elements of the purine salvage pathway involved in converting
adenine to ATP (apt, adk, and ndk), and in converting guanosine
derivatives into AMP (guaC) were up-regulated. Additionally, six
out of the nine ATP synthase genes (atpABEFHI) increased in
expression. One interpretation of this result is that the cell is
responding to a perceived lack of ATP, due to sequestration by
DX, which causes an increase in ATP salvage pathways rather
than de novo biosynthesis pathways.
Discussion
The central focus of the current study was to investigate the
synthetic biology of an artificial protein inside the environment of a
bacterial host organism. We were motivated by the following
question: how would a natural system respond to an encounter with
an unnatural protein obtained from non-biological origins? Would
the expression of a completely man-made protein in a living host
organism reveal something new about biological pathways or help
explain why certain protein folds are not observed in nature?
Because our current understanding of even the most basic of living
systems remains limited, investigations such as this have the ability
to provide new insights into biological systems. Information gained
from these studies could, in principle, be used to create novel
synthetic systems that function in unnatural ways or possibly
discover alternative avenues for therapeutic intervention. In
addition, these types of studies also provide a unique opportunity
to evaluate the properties of man-made proteins in living systems, as
tailor-made proteins have the potential to endow living systems with
synthetic functions that are not found in nature.
During the course of our study, we discovered that E. coli cells
transformed with the DX plasmid experience reduced reproductive
competencyafterthree hoursofinducedgrowth. This changein cell
growth is contemporaneous with the first detectable occurrence of
DX in the cell, and is associated with an observed rise in
intracellular ATP, the transition to a filamentous state, an increase
Figure 7. Electron micrographs of thin sections through embedded E. coli expressing DX. The cells were cultured for 3 hours in liquid
media in the absence (a) or presence (b–d) of inducer. (a) An uninduced cell displaying a forming septum and three membranous spheres marked by
arrows. (b) An example of a filamentous cell expressing DX. Areas marked by arrows indicate regions of chromosomal segregation. (c) Increased
magnification of the boxed area in (b). A selection of membranous structures associated with the surface of the cell is marked with arrows. The arrow
marked with a * indicates structures which have become detached from the cell. Images examined both above and below the plan reveal that this
portion of the cell is not forming a division septum. (d) High magnification image of several spherical structures.
doi:10.1371/journal.pone.0007385.g007
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filamentous phenotype was observed in multiple bacterial strains,
which suggests that DX is targeting a conserved biological pathway.
Microarray analysis showed a downward trend in pathways that
involve the synthesis of important cell building blocks, such as
amino acids, nucleotides, and disaccharides. These observations are
consistent with the interpretation that cells expressing the DX gene
are attempting to conserve ATP through a defense mechanism that
lowers cellular activity along certain ATP-dependent pathways.
While filamentation could be a response to cell stress[36], the
absence of an SOS response in the microarray data leads us to
suspect that its cause is more biochemical than genetic. In addition,
down regulationofzapA couldhelpfacilitatecellfilamentation,since
ZapA is known to counteract FtsZ inhibition by MinC[37]. Within
this same timeframe, a general upward trend was observed in genes
involved in cell motility, sulfur metabolism, and ATP synthesis by
salvage pathways. These genes are consistent with the ability of E.
coli to escape harmful environments and activate secondary
pathways for ATP synthesis.
It is interesting that many of the genes found to be over-
represented in our study were also identified in another study in
which artificial gene networks using natural transcription factors in
novel regulatory networks were constructed in E. coli Top10
cells[38]. In that case, it was discovered that artificial gene
networks containing the flhD or rpoS promoter regions conveyed a
selective advantage on E. coli growth and survival. The authors
speculated that this advantage was due to interference between the
artificial regulatory network and native networks that use the same
component parts. It is intriguing that these same two regulatory
elements were found to be over-represented in E. coli Top10 cells
expressing the DX gene. Since disruption of the flhD gene has been
shown to increase cell division[39], it may not be surprising that
over-expression of flhD in DX expressing cells is associated with a
decrease in cell division. While the authors found that E. coli is
relatively tolerant to the introduction of new regulatory gene
networks, albeit from natural sources, our study leads to the
opposite conclusion, at least with respect to the use of synthetic
proteins from non-natural origins. However, it remains to be seen
whether protein DX is representative of a typical non-biological
protein, or whether the difference between naturally derived and
unnatural components plays an important role in the tolerance of
E. coli cells to artificial parts and networks.
Based on the data collected,wesuggest that the function ofDX as
an ATP-binding protein is responsible for disrupting the energetic
balance within the cell. Several lines of evidence indicate that DX
remains folded when expressed in E. coli. These include the fact that
protein DX was previously crystallized from the soluble fraction of
E. coli lysate[28], the absence of inclusion bodies in the electron
micrographs, and the observation that induced growth leads to an
ATP-related phenotype. This hypothesis is further supported by the
observation that our gene expression data were able to identify
extensive genetic changes relative to an earlier microarray study in
which cell filamentation was induced by an external chemical
agent[40]. We favor a model in which protein DX causes the cell to
behave as if it were nutrient depleted and react by lowering general
cell metabolism and increasing secondary ATP synthesis pathways.
We speculate that the change in intracellular levels of ATP disrupts
cell division by interfering with ATP-dependent proteins like MinD
and FtsA, which are responsible for positioning the division septum
at the cell equator[41,42]. We suspect that this defect in cell division
leads to a filamentous phenotype in which the cell is no longer able
to propagate normally, and this phenotype persists until DX
induction is halted and energetic balance is restored to the cell.
Similar inhibitory effects have been observed in E. coli cells
expressing non-coding intergenic regions of their genome[43].
However, it is unclear whether the peptides encoded by these
regions form stably folded structures with discrete functions. It is
interesting that the degree of filamentation observed in bacteria that
are actively expressing the DX gene is less extensive than the extent
of filamentation observed in other bacterial systems [44]. This
observation, in combination with the fact that DX-expressing
cultures continue to form colonies when plated onto solid media
containing inducer suggests a model where division either slows
down dramatically or frequently produces nonviable progeny. It is
possible that increased cell stress coupled with altered ATP levels
might be causing the cell to relieve this stress by exporting the DX
protein from the cell[45]. This hypothesis is supported by the large
numbers of outer membrane vesicles observed in the electron
micrographs of filamentous cells. Future studies that examine cell
physiology and morphology during the recovery period will help
clarify the final state of the cell.
One unanticipated result to come from this study was the
observation that DX functions as a bacteriostatic agent with an
efficacy that is qualitatively similar to commercial tetracycline.
This was an interesting result because its potential mode of action
differs considerably from traditional antibiotic agents. Currently,
almost all drugs used to treat bacterial infections target one of four
general mechanisms: i) cell wall synthesis; ii) protein synthesis; iii)
nucleic acid synthesis; and iv) metabolite synthesis[46]. Of the
antibiotics that inhibit metabolite synthesis, most target folic acid
synthesis, which is essential for the synthesis and maintenance of
new cell walls[46]. Only a few examples exist where ATP has been
implicated as a possible target for antibacterial activity. Nisin, a
polycyclic peptide antibacterial agent commonly used as a food
preservative, is one example of an antibiotic that depletes
intracellular ATP levels[47]. However, unlike DX, which binds
ATP directly, this agent causes cell death by disrupting the ion
potential and pH gradient across the cell membrane[47]. Although
it is still premature to determine whether ATP is a viable target for
next-generation antibacterial agents, the demand for such drugs
warrants further study of synthetic proteins like DX in cellular
systems[48].
Unlike all previous examples of protein evolution, which start
with a protein found in nature and optimize for such properties as
improved folding stability or alternative function, our protein
originated from an unconstrained pool of synthetic random
sequences. When we began our study is was not clear that a
protein whose entire evolutionary history involved a series of in
vitro selection steps in a test tube would function inside a living cell.
The fact that protein DX elicits an ATP-dependent phenotype in
E. coli, warrants an explanation in terms of protein structure and
the evolutionary forces that give rise to stably folded proteins. One
hypothesis that is consistent with our observations and the general
history of protein evolution is that protein structures are highly
plastic, and thus any selective pressure, whether man-made or
natural, that drives a protein toward improved stability has the
potential to give rise to a native structure. One implication of this
hypothesis is that cellular origin is not the only determinant of
whether a protein will remain functional in a host organism.
Testing this hypothesis will require examining the structural and
functional properties of many additional examples of proteins that
have been evolved in the absence of biological constraints.
In summary, the current study provides the first in-depth
analysis of a non-biological protein in a living host organism. We
found that a synthetic ATP-binding protein from non-natural
origins functions inside living cell by disrupting the normal
energetic balance within the cell. This disruption cascades into a
series of events that limit reproductive competency by inhibiting
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proteins could be used to as novel therapeutics, including next
generation antibiotics, and provides new opportunities for probing
many basic and applied questions in cellular biology.
Materials and Methods
Bacterial Strains, Media and Growth Conditions
All experiments performed in this study involved E. coli TOP10
cells (Invitrogen) unless otherwise stated. Liquid cultures were
grown at 37uC for 14–16 h in Luria-Bertani (LB) media
containing ampicillin (US Biological, 200 mg/ml), and protein
expression was induced by diluting the culture 100-fold into fresh
LB containing arabinose (1 mg/ml).
Construction of Plasmids
The DX and ubiquitin genes were amplified by the polymerase
chain reaction (PCR) from a pmal plasmid [28]. The forward
DNA primer contained the sequence information necessary to add
an E. coli optimized Shine-Dalgarno sequence upstream of the
open reading frame and modify the N-terminus of each protein to
include a Flag protein affinity tag (MDYKDDDDK). In addition,
the PCR primers also contained EcoRI and HindIII restriction
enzyme sites, which were used to clone both genes into the
pBAD18 plasmid[30]. Codon usage for the DX and ubiquitin
genes was optimized for E. coli expression and proper insertion of
both genes was verified by DNA sequencing.
Cell Growth, Expression and Metabolism Studies
Liquid cell cultures containing the DX, ubiquitin, and empty
pBAD18 vector were induced with arabinose. Over the course of
10 hours, four 1 ml aliquots and one 0.5 ml aliquot were removed
at each one-hour interval. The 0.5 ml aliquot was used to measure
cell density at 600 nm using an Eppendorf BioPhotometer. Each
of the 1 ml aliquots were pelleted by centrifugation, frozen at
280uC, thawed on ice, and used in the following manner: the first
aliquot was re-suspended in sterile water, lysed by sonication and
total cell protein was determined by taking the average of three
Bradford measurements; the second aliquot was re-suspended in
1x SDS containing loading buffer and used in a western blot assay,
the third and fourth aliquots were re-suspended in pH 7.4 PBS
and used to measure intracellular ATP levels. In addition, a 1 ml
sample from each cell type was also removed after each hour of
expression, diluted 1000-fold into sterile water, and spotted as a
series of four 10-fold dilutions onto LB-agar plates that either
contained or were devoid of arabinose (1 mg/ml). The cultures
were grown on solid media for 18 hours at 37uC and imaged using
a Bio Rad Gel Doc XR+ system. This experiment was performed
in duplicate using liquid cultures that were grown in the presence
or absence of arabinose.
Western Blotting
Cell samples obtained in the cell growth study were re-
suspended in 1x SDS containing loading buffer (Invitrogen).
Sample volumes were normalized based on the total protein
content determined by the Bradford assay. These samples were
boiled for 5 min and analyzed by SDS polyacrylamide gel
electrophoresis (SDS-PAGE). The resulting gel was transferred
to polyvinylidene difluoride (PVDF) or nitrocellulose membranes
using the Invitrogen iBlot system and FLAG-tagged recombinant
proteins were visualized with horseradish peroxidase (HRP) using
an anti-FLAG antibody (Immunology Consultants Laboratory)
and with a chemiluminescent substrate (SuperSignal, Thermo
Scientific).
Intracellular ATP Assay
Cell samples obtained in the cell growth study were analyzed
using the BacTiter-Glo microbial cell viability assay kit (Promega)
and bioluminescence was detected using a Promega Glomax
luminometer. Cell samples were normalized to total cell protein as
determined by Bradford assay such that the total amount of
protein in each sample was equivalent. A linear calibration was
performed using known quantities of ATP (Sigma) to determine
the absolute quantity of ATP in each sample, and all values
represent the average of three trials.
Immunoprecipitation Assay
E. coli TOP10 cells transformed with pBAD18 containing either
DX, ubiquitin, or the empty vector were induced for 4 h at 37uC.
Cells were harvested and lysed in buffer containing 1 mg/mL
lysozyme, 50 mM Tris HCl (pH 7.5), 100 mM NaCl, 10%
glycerol, 1 mM dithiothreitol (DTT), 0.1% Nonidet-P40, 1 mM
phenylmethanesulphonylfluoride (PMSF), and protease inhibitor
cocktail (Roche). Lysate was clarified by centrifugation at 21,130
Xg for 45 min at 4uC and filtered through a 0.22 mm sterile syringe
filter unit. DX was immobilized by adding 1 mg of crude protein
(determined by Bradford assay) to ANTI-FLAGH M2-Agarose
Affinity Gel (Sigma) in binding buffer (similar to the lysis buffer,
but without lysozyme and glycerol and supplemented with 15 mM
EDTA). Protein and affinity gel were incubated for 2 h at 4uC,
washed three times in wash buffer (binding buffer without protease
inhibiter cocktail). Samples were analyzed by SDS-PAGE gel
(NuPAGE, Invitrogen) and imaged using SilverXpress silver
staining kit (Invitrogen).
Toxicity Analysis
Cells containing the DX plasmid were cultured for 10 hours
under induction. These samples were centrifuged at 3000 Xg at
4uC for 5 min, washed twice with fresh LB, and re-suspended in
the same volume of LB devoid of the arabinose inducer. Over the
course of an 8 hour experiment, cell aliquots (1 ml) were diluted
1000-fold into sterile water and spotted as a series of four further
10-fold dilutions onto LB-agar plates. A series of control cells
containing the empty pBAD18 vector were cultured in an identical
manner with the exception that these cells either contained
kanamycin (US Biological, 50 mg/ml), tetracycline (Sigma, 10 mg/ml),
or no additional antibiotic. The control cells were washed, re-
suspended, and allowed to recover for the same period of time in fresh
LB before spotting onto solid media. This experiment was repeated
and seven replicate spots from each one-hour time point were analyzed
using a 2-way ANOVA test of variance. Results were considered
significant if p,0.05, very significant if p,0.01 and extremely
significant if p,0.001.
Cell Morphology Imaging
Cells transformed with pBAD18 plasmids containing either DX,
ubiquitin, or the empty vector were grown under induction for 1–
9 hours, harvested after 2, 3, 4, 6, 8, and 9 hours of growth, and
fixed in 2% gluteraldahyde overnight. These cells were visualized
at 406 magnification using a Nikon Eclipse TE300 model
microscope using a phase contrast objective. In a second
experiment, 100-fold dilutions of overnight growths of cells
containing plasmid pBAD18-DX were cultured for 1–8 hours
both in the presence and absence of arabinose. These cells were
harvested each hour and fixed in 2% gluteraldahyde overnight
before imaging between 10 and 20 fields of view for each sample at
406 magnification using a Fisher Micromaster phase contrast
microscope. These images were processed using MATLAB
Biology of a Synthetic Protein
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areas.
Electron Microscopy
Overnight cultures containing pBAD18 plasmid with the DX
insert were diluted 100-fold into liquid media either containing or
devoid of arabinose inducer. Liquid cultures were allowed to grow
for 3, 4, or 5 hours before being fixed in 2% gluteralehyde in
phosphate buffered saline (PBS) (100 mM NaPO4 (pH 7.0) and
100 mM NaCl). Cells were washed twice, re-suspended in PBS,
and embedded in 1% agarose. Agarose pellets were washed twice
in PBS and post-fixed in 1% osmium tetroxide in PBS for 2 hours.
Pellets were then washed twice in distilled water (diH2O), left in
diH2Oa t4 uC overnight, washed twice again in diH2O, incubated
in 1% uranyl acetate for 2 h, and washed 4x in diH2O. Cells were
dehydrated by incubating in an ascending series (20% increments)
of 10 min acetone washes with three final wash steps in 100%
acetone. Dehydrated cells were then infiltrated with Spurr’s epoxy
resin on a rotating wheel using an ascending series similar to
acetone (25% increments) with three final washes in 100% resin.
Cells were embedded in fresh resin and polymerized for 24 h at
60uC. 60 nm section were cut using a Leica Ultracut-R microtome
and thin sections were post-stained for 5 min with 1% uranyl
acetate and 3 min with Sato’s lead citrate. Sections were imaged
with a Philips CM12 operated at 80 kV and images were
generated with a Gatan 791 CCD camera.
Microarray Analysis
Overnight cultures of cells containing the pBAD18-DX plasmid
were diluted 25-fold into media either with or without arabinose
inducer. Aliquots were taken every 30 min from time 0 until
4 hours post-induction. Total RNA was extracted using an
Invitrogen PureLink Micro-to-Midi RNA purification kit. RNA
was analyzed using an Agilent 2100 Bioanalyzer and RNA
samples with a RNA integrity number (RIN) of less than 7 were
excluded and repeated. cDNA was generated with a FairPlay III
microarray labeling kit using random primers. cDNA was purified
using an Invitrogen PureLink PCR purification kit and labeled
with Molecular Probes Alexa-647 (for RNA from induced cells) or
Alexa-555 (for RNA from uninduced cells) following the
manufacturer’s protocol. Labeled cDNA from each of the eight
time points was hybridized to a microarray slide containing 8
separate copies of the E. coli genome (Agilent Microarray Design
ID 020097) according to instructions provided by the manufac-
turer. Slides were imaged using an Agilent G2565 BA scanner.
Expression data was extracted using GenePix Pro v6.0 software
and the provided GAL file. Expression data was analyzed using
GeneSpring (Agilent) and MATLAB’s bioinfomatics software suit
(see supplementary information). Data from the 2.5 hours post-
induction sample were excluded from this analysis because the
uninduced RNA failed to label properly. Microarray data was
deposited in the NCBI microarray database Gene Expression
Omnibus with the accession code GSE17568.
Supporting Information
Figure S1 Colonies grown from cells expressing DX show a
distinct morphological phenotype which increases in severity as
the as the length of induction time increases. Maintenance of DX
expression on solid media also increases the severity of this
phenotype.
Found at: doi:10.1371/journal.pone.0007385.s001 (1.98 MB TIF)
Figure S2 CFU counts of DX-expressing and control cells
during eight hours of induction and recovery. Each time point
represents the average number of CFUs obtained from 7–10 mL
spots and the error bars represent the standard deviation.
Found at: doi:10.1371/journal.pone.0007385.s002 (3.93 MB TIF)
Table S1 CFU counts of cultures expressing DX
Found at: doi:10.1371/journal.pone.0007385.s003 (0.06 MB
PDF)
Table S2 Genes identified by linear regression as having
increased expression over time.
Found at: doi:10.1371/journal.pone.0007385.s004 (0.15 MB
PDF)
Table S3 Genes identified by linear regression as having
decreased expression over time.
Found at: doi:10.1371/journal.pone.0007385.s005 (0.13 MB
PDF)
Table S4 Time dependent expression of chemotaxis genes.
Found at: doi:10.1371/journal.pone.0007385.s006 (0.09 MB
PDF)
Table S5 Time dependent expression of sulfur metabolism
genes.
Found at: doi:10.1371/journal.pone.0007385.s007 (0.07 MB
PDF)
Table S6 Time dependent expression of the rpoS regulon.
Found at: doi:10.1371/journal.pone.0007385.s008 (0.08 MB
PDF)
Table S7 Time dependent expression of SOS pathway genes.
Found at: doi:10.1371/journal.pone.0007385.s009 (0.05 MB
PDF)
Table S8 Time dependent expression of cell division genes.
Found at: doi:10.1371/journal.pone.0007385.s010 (0.10 MB
PDF)
Table S9 Expression over time of genes involved in ATP
biosynthesis.
Found at: doi:10.1371/journal.pone.0007385.s011 (0.10 MB
PDF)
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